Kala et al. [78] showed that a combination of resveratrol (15 μM) and pterostilbene (5 μM) decreases hTERT expression through sirtuin 1 (SIRT1) and DNMT inhibition in HCC1806 breast cancer cells. Here, SIRT1 is linked to breast carcinoma.